HSDL2: A Protein Encoding A Key Regulator of Cell Signaling and Cellular Homeostasis

Target Name: HSDL2

NCBI ID: G84263

HSDL2

HSDL2: A Protein Encoding A Key Regulator of Cell Signaling and Cellular Homeostasis

Hydroxysteroid dehydrogenase like 2 (HSDL2) is a gene that encodes a protein located in the endoplasmic reticulum (ER) of the cell. The ER is a network of organelles responsible for protein synthesis, quality control, and degradation. HSDL2 is a member of the superfamily of cytoskeletal proteins known as the coiled-coil proteins, which are involved in various cellular processes such as cell signaling, cytoskeletal organization, and chromatin regulation.

The HSDL2 gene was first identified in the late 1990s using genetic screening techniques. It is located on chromosome 16, specifically on the qp136 region. HSDL2 is a single gene with four exons, which means it has four different versions of the gene. The most abundant variant is called HSDL2-AS, which has 254 amino acid residues. The other variants, HSDL2-BP, HSDL2-BS, and HSDL2-CA, have between 214 and 253 amino acid residues, respectively.

HSDL2 is a protein that plays a critical role in the synthesis and degradation of steroids, which are a diverse family of hormones that regulate various physiological processes in the body. Steroids are involved in the regulation of inflammation, bone and muscle growth, and hormone signaling. The synthesis of steroids typically involves the synthesis of the precursor hormone, which is then converted into the final product by enzymes in the endoplasmic reticulum. HSDL2 is involved in this process by catalyzing the conversion of the precursor hormone to the final product.

HSDL2 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in the regulation of cell adhesion, migration, and the association with various signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

HSDL2 has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of cytokine production and the modulation of immune cell function. This is important for the regulation of inflammatory responses, which are critical for maintaining tissue homeostasis and for fighting off infections.

The HSDL2 gene has also been shown to be involved in the regulation of protein homeostasis. This is the process by which cells maintain the proper ratio of protein synthesis to degradation. This is important for maintaining cellular homeostasis and for the regulation of cellular processes such as cell signaling and cytoskeletal organization.

HSDL2 has also been shown to be involved in the regulation of cell cycle progression. This is the process by which cells divide and grow, and is critical for the development and progression of cancer. HSDL2 has been shown to play a role in the regulation of the G1 phase of the cell cycle, which is the stage of cell growth and preparation for cell division.

HSDL2 is also involved in the regulation of DNA replication and repair. This is important for the regulation of gene expression and the maintenance of cellular genetic stability.

In conclusion, HSDL2 is a gene that encodes a protein that plays a critical role in the regulation of various cellular processes, including cell signaling, cytoskeletal organization, and protein homeostasis. Its functions are important for the development and progression of many diseases, including cancer and autoimmune diseases. Therefore, HSDL2 is a potential drug target and a biomarker for various diseases.

Protein Name: Hydroxysteroid Dehydrogenase Like 2

Functions: Has apparently no steroid dehydrogenase activity

The "HSDL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSDL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets